Business Combination (Tables)

6 Months Ended

Jun. 30, 2023

Business Combination

summary the preliminary estimated fair value

Description	Fair Value as of January 9, 2023
Fair value of 14,649.591 Series X Convertible Preferred Stock issued	$	69,140
Fair value of Old Catheter’s fully vested stock options		3,404
Total purchase price	$	72,544

summary Of preliminary purchase price allocations

Description	Fair Value
Assets acquired:
Cash and cash equivalents	$	15
Accounts receivable		71
Inventories		52
Prepaid expenses and other current assets		23
Property and equipment, net		26
Lease right-of-use assets		119
Other assets		8
Developed technology		27,014
Customer relationships		62
Trademarks		1,285
Goodwill		60,934
Total assets acquired	$	89,609
Liabilities assumed:
Accounts payable	$	922
Accrued expense		1,389
Interest payable		198
Convertible promissory note		250
Lease liability		124
Royalties payable		14,182
Total liabilities assumed		17,065
Total purchase price	$	72,544

Schedule of acquisition date fair values and estimated useful lives

Intangible Assets	Estimated Fair Value		Estimated Useful Life in Years
Developed technology – VIVO	$	8,244		15
Developed technology – LockeT		18,770		14
Customer relationships		62		6
Trademark – VIVO		876		9
Trademark – LockeT		409		9
	$	28,361

Schedule of Basic and diluted net loss per share - on a pro forma basis

	Three Months Ended						Six Months Ended
	June 30,						June 30,
	2023			2022			2023			2022
Revenues	$	96		$	51		$	184		$	146
Net loss		(1,576	)		(9,906	)		(68,146	)		(16,872	)
Net loss attributable to common stockholders		(1,576	)		(9,906	)		(68,946	)		(16,872	)
Basic and diluted net loss per share – on a pro forma basis (unaudited)	$	(0.29	)	$	(15.27	)	$	(16.81	)	$	(31.97	)